← Open Payments lookup

MATTHEW FLYNN: Open Payments

NPI 1760618292 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$444 in 24 payments from 7 companies in 2025. Trend: 2023 $336 · 2024 $474 · 2025 $444

Food & beverage: $444
CompanyPaymentsAmount
GlaxoSmithKline, LLC.13$213
Mallinckrodt Hospital Products Inc.3$75
Merck Sharp & Dohme LLC3$49
AstraZeneca Pharmaceuticals LP2$41
ABBVIE INC.1$33
3B Medical, Inc.1$17
Electromed, Inc.1$16

Products named: TRELEGY ELLIPTA, ACTHAR, ZERBAXA, TEFLARO, AIRSUPRA, TEZSPIRE, LUNA, NUCALA.

Industry payments across MS — which companies pay providers there.